We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Chiropractic for Hypertension in Patients (CHiP)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01020435
First Posted: November 25, 2009
Last Update Posted: October 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Palmer College of Chiropractic
  Purpose
The investigators propose a prospective randomized 2 arm parallel observer-blinded phase II clinical study comparing a distinct method of upper cervical chiropractic manipulation to a sham technique in 50 individuals with stage I hypertension (systolic blood pressure (SBP): 140-159 mm Hg; diastolic blood pressure (DBP):90-99 mm Hg).

Condition Intervention Phase
Hypertension Other: Spinal Manipulation Other: Sham Spinal Manipulation Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Upper Cervical Manipulation for Patients With Stage 1 Hypertension

Resource links provided by NLM:

MedlinePlus related topics: Chiropractic
U.S. FDA Resources

Further study details as provided by Palmer College of Chiropractic:

Primary Outcome Measures:
  • Feasibility of conduction a full-scale randomized control trial to evaluate the efficacy of Toggle Recoil chiropractic manipulation for patients with stage 1 hypertension [ Time Frame: 6 weeks ]
    To assess the feasibility of conducting a full-scale randomized controlled trial to evaluate the efficacy of Toggle Recoil chiropractic manipulation for patients with stage I hypertension. We will assess: 1) the success of blinding clinic personnel to treatment allocation; 2) the ability to effectively use Academic Health Center faculty as research clinicians; 3) the ability to take blood pressure measurements according to protocol and keep clinic personnel blinded; 4) the ability to retain participants who are randomized to the placebo treatment (n=25) and the active treatment (n=25).


Secondary Outcome Measures:
  • Estimate the effect size and variability of change in systolic and/or diastolic blood pressure [ Time Frame: 6 weeks ]
    To estimate the effect size and variability of change in systolic and/or diastolic blood pressure over a six week treatment period to use in planning a full-scale randomized controlled trial and to assess the believability of the placebo manipulation
Enrollment: 51
Study Start Date: October 2010
Study Completion Date: May 2012
Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Spinal Manipulation High Velocity
This non-rotary upper cervical procedure uses an impulse thrust with a controlled depth (high velocity). The participant's head is supported by a specially designed cushion and the doctor usually approaches the participant from in front of his or her head to contact soft tissue over the atlas transverse process, posterior to the lateral mass or occasionally on the C2 lamina or spinous process, with the pisiform process of one hand. The thrust is delivered by a contraction of the triceps muscles of both arms, which straightens the arms and applies the thrust to the participant.
 Other: Spinal Manipulation
The procedure in its broadest definition describes the application of a load (force or displacement) to specific body tissues (usually vertebral joints) with therapeutic intent. The mechanical characteristics of SM can vary in terms of its duration and amplitude, (hence, the rate at which it is applied), as well as its anatomical location, choice of levers, direction of force application, and the vehicle used to apply the force (manually or mechanically assisted).
Placebo Comparator: Sham Spinal Manipulation
The sham assessment procedures will be similar to the active group. It has been developed and validated by Vernon et al.
 Other: Sham Spinal Manipulation
The sham assessment procedures will be the same as those in the high velocity treatment group. The sham intervention is identical to this treatment protocol except for the placement of the treating clinicians pisiform contact. The force and vector applied will be the same.
Other Name: Sham

Detailed Description:
More than 50 million Americans suffer from hypertension, a disease with far-reaching public health impact causing or contributing to 7.1 million deaths yearly at an estimated annual incremental direct cost of $54 billion per year. Common treatments include antihypertensive medications and lifestyle modifications. While these treatments have been shown to be effective, only about 30% of hypertensive patients achieve blood pressure goals. Based on a recently published study (Bakris et al, 2007), one unique non-pharmaceutical approach may be a non-rotary type of upper cervical spinal manipulation to align the first cervical vertebra (atlas) performed by a doctor of chiropractic. We propose to conduct a similar study with a more commonly known chiropractic technique called Toggle Recoil. We propose a prospective randomized 2 arm parallel observer-blinded phase II clinical study comparing a distinct method of upper cervical chiropractic manipulation to a sham technique in 50 (25 in each group) individuals with Stage I hypertension (systolic blood pressure (SBP); 140-159 mm Hg or diastolic blood pressure (DBP):90-99 mm Hg). Patients will be seen by doctors of chiropractic twice each week for 6 weeks and outcomes will be collected at baseline, 3 weeks, and 6 weeks after enrollment. The primary outcome measure will be change in SBP and the primary endpoint will be at the week 6 assessment.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   21 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age > 21 and < 75
  • Documented Stage I Hypertension

Exclusion Criteria:

  • Cardiovascular disorders (Angina pectoris, symptom of CHD; Hemodynamically significant valvular heart disease; Second or Third degree heart block without pacemaker; Stroke, MI, CV surgery within the past 12 months; Claudication, Aortic Coarctation)
  • Defibrillator
  • Autoimmune Arthropathies
  • Pregnancy
  • Unwillingness to stop other forms of manual therapy during study
  • Unwillingness to sign ICD or preliminary consent
  • Intention to move from the area during the next 4 months
  • Unwillingness to participate in any of the treatment groups
  • Avg SBP<140 or >159mm Hg (AND) Avg DBP<90 or >99mm Hg
  • Any single SBP > 160mm Hg or DBP> 100
  • BMI > 40
  • Prescription medications with increased risk for CVA
  • Current use of anti-coagulant medication/blood thinners
  • Active drug or alcohol addiction or abstinent < 1 year
  • Psychiatric diagnosis that would limit patient compliance
  • Serious concomitant medical illness
  • Contraindication(s) to treatment
  • Electrolyte abnormalities seen on lab test
  • Renal Failure w/ creatinine >2.5mg/dL
  • Abnormal Liver function tests
  • Anemia with hematocrit < 30%
  • Glucose in Urine
  • Serum potassium <3.4 @ baseline
  • S/S Renal artery stenosis
  • Quebec Task Force Classification 4-9
  • Self-reported Arnold Chiari malformation
  • Spinal or paraspinal tumors
  • Dx with disorder that exhibit spinal joint hypermobility (Marfan Syndrome, Ehlers-Danlos Syndrome, Osteogenesis imperfecta)
  • Unstable endocrine disorders
  • Osteoporosis
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01020435


Locations
United States, Iowa
Palmer College of Chirpractic
Davenport, Iowa, United States, 52803
Sponsors and Collaborators
Palmer College of Chiropractic
Investigators
Principal Investigator: Christine M Goertz, DC, PhD Palmer College of Chiropractic
  More Information

Additional Information:
Effect of Spinal Manipulation of Upper Cervical Vertebrae on Blood Pressure: Results of a Pilot Sham-Controlled Trial  This link exits the ClinicalTrials.gov site
Inter-examiner reliability of the interpretation of paraspinal thermographic pattern analysis  This link exits the ClinicalTrials.gov site

Publications:

Responsible Party: Palmer College of Chiropractic
ClinicalTrials.gov Identifier: NCT01020435     History of Changes
Obsolete Identifiers: NCT01230372
Other Study ID Numbers: CHiP
First Submitted: November 24, 2009
First Posted: November 25, 2009
Last Update Posted: October 12, 2017
Last Verified: September 2016

Keywords provided by Palmer College of Chiropractic:
Hypertension

Additional relevant MeSH terms:
Hypertension
Vascular Diseases
Cardiovascular Diseases